YS
Price:
$1.02
Market Cap:
$1.39B
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. It develops a proprietary PIKA immunomodulating technology platform and a series of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.[Read more]
Industry
Biotechnology
IPO Date
2021-08-05
Stock Exchange
NASDAQ
Ticker
YS
According to YS Biopharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -1.82. This represents a change of 27.22% compared to the average of -1.43 of the last 4 quarters.
The mean historical PE Ratio of YS Biopharma Co., Ltd. over the last ten years is -30.14. The current -1.82 PE Ratio has changed 504.30% with respect to the historical average. Over the past ten years (40 quarters), YS's PE Ratio was at its highest in in the September 2022 quarter at 191.01. The PE Ratio was at its lowest in in the June 2022 quarter at -76.66.
Average
-30.14
Median
-29.85
Minimum
-53.55
Maximum
-7.03
Discovering the peaks and valleys of YS Biopharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 79.39%
Maximum Annual PE Ratio = -7.03
Minimum Annual Increase = -86.87%
Minimum Annual PE Ratio = -53.55
Year | PE Ratio | Change |
---|---|---|
2023 | -7.03 | -86.87% |
2022 | -53.55 | 79.39% |
The current PE Ratio of YS Biopharma Co., Ltd. (YS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-30.14
5-year avg
-30.14
10-year avg
-30.14
YS Biopharma Co., Ltd.’s PE Ratio is less than Revelation Biosciences, Inc. (-0.13), less than Cardio Diagnostics Holdings, Inc. (-0.79), less than Biodexa Pharmaceuticals Plc (-0.18), less than ZyVersa Therapeutics, Inc. (-0.00), greater than Sonnet BioTherapeutics Holdings, Inc. (-1.88), less than Allarity Therapeutics, Inc. (-0.10), less than Kiromic BioPharma, Inc. (-1.34), greater than Immix Biopharma, Inc. (-2.41), less than CNS Pharmaceuticals, Inc. (-0.16), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Navidea Biopharmaceuticals, Inc. (0.03), less than Virios Therapeutics, Inc. (-0.76), greater than Zura Bio Limited (-5.60), less than Quoin Pharmaceuticals, Ltd. (-0.33), less than Virax Biolabs Group Limited (-0.67),
Company | PE Ratio | Market cap |
---|---|---|
-0.13 | $3.24M | |
-0.79 | $10.73M | |
-0.18 | $2.32M | |
-0.00 | $2.65M | |
-1.88 | $2.50M | |
-0.10 | $5.63M | |
-1.34 | $1.69M | |
-2.41 | $49.14M | |
-0.16 | $7.15M | |
-0.00 | $941.00 | |
0.03 | $100.08K | |
-0.76 | $206.50K | |
-5.60 | $178.25M | |
-0.33 | $2.95M | |
-0.67 | $8.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like YS Biopharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like YS Biopharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is YS Biopharma Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for YS Biopharma Co., Ltd. (YS)?
What is the highest PE Ratio for YS Biopharma Co., Ltd. (YS)?
What is the 3-year average PE Ratio for YS Biopharma Co., Ltd. (YS)?
What is the 5-year average PE Ratio for YS Biopharma Co., Ltd. (YS)?
How does the current PE Ratio for YS Biopharma Co., Ltd. (YS) compare to its historical average?